| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,533 |
3,192 |
$226K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,859 |
2,606 |
$138K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
411 |
339 |
$29K |
| 99215 |
Prolong outpt/office vis |
235 |
221 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,352 |
1,181 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,176 |
1,090 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
60 |
49 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,199 |
892 |
$6K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
276 |
249 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
406 |
380 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
56 |
55 |
$547.13 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
76 |
73 |
$540.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
293 |
260 |
$430.78 |
| 36415 |
Collection of venous blood by venipuncture |
288 |
271 |
$394.00 |
| 99000 |
|
86 |
85 |
$290.50 |
| 81003 |
|
152 |
143 |
$285.46 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
14 |
$213.46 |
| 82962 |
|
44 |
41 |
$78.00 |
| 90756 |
|
15 |
14 |
$0.00 |